Journals / Journal of Cell and Molecular Biology / 2005 / Cilt: 4 - Sayı: 1

Miyokard infarktüsünde angiotensin dönüştürücü enzim (ADE) gen polimorfizminin biyokimyasal temelleri

The biochemical fundamentals of angiotensin converting enzyme (ACE) gene polymorphism in myocardial infarction

Pages
1–8
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

By the help of these studies the risk factors of genetic origin, using the genetic indicators and new risk factors, and supporting the information by some easily performed biochemical experiments would supply great easiness in diagnosis and cure and save life.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myocardial Infarction (MI) is the most important reason of mortality and morbidity in developed countries.
📊
Key Findings & Data:In recent years, a lot of scientific studies have increased on some genetic risk factors responsible from the formation of MI.
💡
Conclusion & Impact:By the help of these studies the risk factors of genetic origin, using the genetic indicators and new risk factors, and supporting the information by some easily performed biochemical experiments would supply great easiness in diagnosis and cure and save life.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Myocardial Infarction (MI) is the most important reason of mortality and morbidity in developed countries. It is detected that about half of the deaths, no matter what reason is, in the USA is sourced from MI. In recent years, a lot of scientific studies have increased on some genetic risk factors responsible from the formation of MI. One of the most popular of these is searching for the relations between the I/D polymorphism in the ACE gene and MI. In this study, it is assumed that ACE I/D gene polymorphism is a useful indicator in the detection of the risk of cardiovascular disease, the better control of the people in high risk group and the optimal cure to start at an earlier stage. By the help of these studies the risk factors of genetic origin, using the genetic indicators and new risk factors, and supporting the information by some easily performed biochemical experiments would supply great easiness in diagnosis and cure and save life.

Özet

Gelişmiş ülkelerde en başta gelen morbidite ve mortalite nedeni miyokard infarktüsü ve koroner arter hastalıklarıdır. Miyokard infarktüsü ABD'de ve diğer birçok gelişmiş ülkede tüm nedenlere bağlı ölümlerin yaklaşık yarısından sorumludur. Son zamanlarda miyokard infarktüsü oluşumundan sorumlu olabilecek bazı genetik risk faktörleri üzerinde çalışmalar artmıştır. Bunların arasında en popüler olanlarından biri Angiotensin Dönüştürücü Enzim (ADE) genindeki I/D polimorfizmi ve miyokard infarktüsünün ilişkisini araştıran çalışmalardır. Miyokard infarktüsü ve koroner arter hastalıklarına yol açan genetik belirteçlerin saptanması, bu hastalıkları önleme ve tedavi çalışmalarında kolaylık sağlayabilecektir. Bu genetik belirteçlerin önceden saptanması durumunda klinik belirtiler ve kardiyovasküler komplikasyonlar ortaya çıkmadan yüksek risk grubundaki kişiler belirlenebilecekler ve uygun tedavi için takibe alınabileceklerdir. Tüm bu çalışmalar ADE gen polimorfizminin kardiyovasküler riskin tahmininde, yüksek risk gruplarındaki hastalara erken ve etkili tedavinin planlanması ve Önceden belirlenmesinde ışık tutabileceği düşüncesinden hareketle sürdürülmektedir.

🔖

Cite This Article

KAYHAN, F. E., SESAL, C. (2022). Miyokard infarktüsünde angiotensin dönüştürücü enzim (ADE) gen polimorfizminin biyokimyasal temelleri. Journal of Cell and Molecular Biology, Cilt: 4 - Sayı: 1, 1–8. https://ajindex.com/articles/560680

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TIA, Jensen G and Tybjaerg-Hansen A. AACE gene polymorphism: Ischemic heart disease and longevity in 10 150 individuals. A case-referent and retrospective cohort study based on the Kopenhagen City Heart Study. Circulation. 95:2358-2367, 1997.
  2. Aldermann MH, Maddhavan S, Ooi WL, Cohen H, sealey JE and Laragh JH. Assocition of the renin-sodium profile with the risk of MI in patients with hypertension. N Engl J Med. 324:1098-1104,1991.
  3. Arbustini E, Grasso M and Fasani R. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosklerosis and myocardial infarction. Br Heart J. 74:584-591,1995.
  4. Arca M, Panniteri G and Campagna F. ACE gene polymorphism is not associated with coronary artery atherosclerosis and MI in a sample of Italian patients. Eur J Clin Invest. 28:485-490,1998.
  5. Badenhop RF, Wang XL and Wilcken DEL. ACE genotypes in children and coronary events in their grandparents. Circulation. 91:1655-1658,1995.
  6. Beohar N, Damaraju S, Prather A, Yu Q-T, Raizner A, Kleiman NS, Roberts R and Marion AJ. ACE genotyp¤e DD is a risk factor for coronary artery disease. J Invest Med. 43:275-280,1995.
  7. Blundell T, Sibanda BL and Pearl L. Three-dimensional structure, specifity and catalytic mechanism of renin. Nature. 304:273-275, 1983.
  8. Bockxmeer FM, Mamotte C D and Burke V, Taylor RR. ACE Gene Polymorphism and Coronary Heart Disease. Clin. Sci., 99(3), 247-251, 2000.
  9. Bohn M, Berge KE, Bakken A, Eriksen J and Berg K. Insertion/deletion polymorphism at the locus for ACE and parental istory of MI. Clin Genet. 44:298-301,1993.
  10. Bohn M, Berge KE, Bakken A, Erikssen J and Berg K. Insertion/deletion polymorphism at the locus for angiotensin converting enzyme and myocardial infarction. Clin Genet. 44:292-297, 1993. Bunning P and Riordan JF. Sulfate potentiation of the chloride activation of the ACE. Biochemistry. 26:3374-3377,1987.
  11. Bunning P, Holmquist B and Riordan JF. Substrate specifity and kinetic characteristics of angiotensin converting enzyme. Biochemistry. 22:103-110, 1983.
  12. Caldwell PRB, Seegal BC, Hsu KC, Das M and Soffer RL. Angiotensin-converting enzyme: vascular endothelial localization. Science. 191:1050-1051, 1976.
  13. Cambien F, Poirier O and Lecerf L. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:641-644, 1992.
  14. Canavy I, Henry M, Morange PE, Tiret L, Poirier O, Ebagosti A